Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen |
10.06.2025 15:07:47
|
Form 8.3 - Dalata Hotel Group plc
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | State Street Global Advisors & Affiliates |
Company dealt in | Dalata Hotel Group plc |
Class of relevant security to which
the dealings being disclosed relate (Note 2) | €0.01 ordinary shares |
Date of dealing | 09 June 2025 |
2. INTERESTS AND SHORT POSITIONS
(110) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long | Short | |||
Number | (%) | Number | (%) | |
(1) Relevant securities | 2,290,303 | 1.08297% | ||
(2) Derivatives (other than options) | N/A | N/A | ||
(3) Options and agreements to
purchase/sell | N/A | N/A | ||
Total | 2,290,303 | 1.08297% |
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||
Number | (%) | Number | (%) | |
(1) Relevant securities | N/A | |||
(2) Derivatives (other than options) | N/A | |||
(3) Options and agreements to purchase/sell | N/A | |||
Total | N/A |
3. DEALINGS (Note 4)
(110) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit (Note 5) |
Purchase | 702 | 6.25 |
(b) Derivatives transactions (other than options transactions)
Product name,
e.g. CFD | Nature of transaction
(Note 6) | Number of relevant securities
(Note 7) | Price per unit
(Note 5) |
N/A |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name,
e.g. call option | Writing, selling,
purchasing varying etc. | Number of
securities to which the option relates (Note 7) | Exercise
price | Type, e.g.
American, European etc. | Expiry
date | Option money
paid/received per unit (Note 5) |
N/A |
(ii) Exercising
Product name,
e.g. call option | Number of securities | Exercise price per
unit (Note 5) |
N/A |
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction
(Note 8) | Details | Price per unit
(if applicable) (Note 5) |
N/A |
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. |
N/A |
Is a Supplemental Form 8 attached? (Note 9) | N4 |
Date of disclosure | 10 June 2025 |
Contact name | Sreejesh Menon, Suresh Kumar |
Telephone number | +918067415013 |
If a connected EFM, name of offeree/offeror with which connected | N/A |
If a connected EFM, state nature of connection (Note 10) | N/A |

Analysen zu Mitsubishi Materials Corp
Abgestürzte Blue Chip Aktien – Wall Street Live mit Tim Schäfer
Tim Schäfer live aus New York – dieses Mal mit einem spannenden Blick auf abgestürzte Blue-Chip-Aktien, bei denen sich ein Einstieg lohnen könnte. Gemeinsam mit David Kunz analysiert Tim prominente Verlierer der letzten Monate, die möglicherweise vor einer Erholung stehen.
Themen im Video:
🔹 Merck & Co. (USA) – Probleme mit Impfstoffen und Patentlaufzeiten
🔹 Pfizer – Wachstumsdruck durch auslaufende Patente
🔹 United Health – Ermittlungen und steigende Gesundheitskosten
🔹 Novo Nordisk – Abnehmspritze, Wettbewerb und Marktkorrektur
🔹 Nike – Konsumflaute und neue Konkurrenz
🔹 Estée Lauder – Kursabsturz, China-Schwäche und Hoffnung auf Turnaround
🔹 Campbell Soup – Value-Aktie mit attraktiver Dividende
🔹 Regeneron – Erfolgreiche Gründerstory mit Herausforderungen
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
UBS am 12.06.2025
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Handelsstreit im Fokus: US-Börsen schliessen freundlich -- SMI letztlich wenig bewegt -- DAX schliesslich tiefer -- Asiens Börsen letztlich mehrheitlich im MinusDer heimische Aktienmarkt zeigte sich am Donnerstag kaum verändert. Der deutsche Aktienmarkt notierte mit deutlichen Abgaben. Die Wall Street zeigte sich am Donnerstag mit einem kleinen Plus. An den asiatischen Börsen waren am Donnerstag mehrheitlich rote Vorzeichen zu sehen.
finanzen.net News
Datum | Titel |
---|---|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |